CDC42 and endometrial carcinoma: The top incidences of Cdc42 amplification (cBioPortal) are in endometrial carcinoma, bladder urothelial carcinoma, sarcoma and ovarian epithelial tumours, and suggest an increase in protein levels and therefore signalling.